Adverse events associated with bimekizumab for moderate-to-severe plaque psoriasis: A retrospective, multicenter, post-hoc analysis by Nikki Zangenah, BA, Maria Vazquez-Machado, BS, Nicole Loranger, BS, Soha Elshaboury, RPH, Kimberly Hashemi, MD, Avery H. LaChance, MD, MPH

Get full text